Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 6:53 p.m.

    📋 BioCryst Pharmaceuticals Inc (BCRX) - Financial Results

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 16:28:37

    Event Type: Financial Results

    Event Details:

    BioCryst Pharmaceuticals Inc (BCRX) Reports the reporting period Financial Results BioCryst Pharmaceuticals Inc (BCRX) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: $601 Million
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: $151 million

    📊 Key Financial Metrics:

    Metric Value
    Revenue $601 Million
    Cash $151 million

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BioCryst Pharmaceuticals Inc
    • Ticker Symbol: BCRX

Search

News categories